trending Market Intelligence /marketintelligence/en/news-insights/trending/SbWokrbokRav4FvrR_bkyg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Thermo Fisher's Zika diagnosis kit gets emergency FDA authorization

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Thermo Fisher's Zika diagnosis kit gets emergency FDA authorization

The U.S. Food and Drug Administration authorized the emergency use of Thermo Fisher Scientific Inc.'s Zika virus diagnosis kit.

The authorization for the company's TaqPath Zika kit only covers the diagnosis of that particular virus and is not meant to be used for the diagnosis of any other infection.

It has not been FDA-cleared or approved and can only be used by certified laboratories.